维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Callander NS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Immunohistochemical identification of tissue factor in solid tumors显示文摘	Callander NS Varki N Rao LV	1992	Cancer1992，70，5：	1
2	Severe, late-onset graft-versus-host disease in a liver trans- plant recipient documented by chimerism analysis 显示文摘	Pollack MS Speeg KV Callander NS	2005	Hum Immunol2005，66，1：	1
3	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS	2010	Lancet oncol2010，11，1：	1
4	Lenalidomideplus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosedmultiple myeloma: an open-label randomised controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS	2010	Lancet Oncol2010，11，1：	1
5	Lenalidomide plus high-dose 'dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS	2010	Lancet Oncol2010，11，1：	1
6	Severe, late onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis 显示文摘	Pollack MS Speeg KV Callander NS etal	2005	Hum Immunol2005，66，1：	1
7	Lenalidomide plushigh-dose dexamethasone versus lenalidomide plus low-dose dex-amethasone as initial therapy for newly diagnosed multiple myelo-ma: an open-label randomised controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS	2010	Lancet Oncol2010，，：	1
8	Thalidomide maintenance following high - dose melphalan with autologous stem cell support in myeloma 显示文摘	chang JE Juckett MB Callander NS	2008	Clin Lymphoma Myeloma2008，8，3：	1
9	Bortezomib-Resistant nuclear factor-kappaB Activityin Multiple myeloma cells 显示文摘	Markovlna S Callander NS OConnor SL	2008	Mol Cancer Res2008，6，8：	1
10	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diag- nosed multiple myeloma: an open-label randomised eontrolled trial显示文摘	RAJKUMAR SV JACOBUS S CALLANDER NS	2010	The Laneet Oneology2010，11，1：	1
11	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma:an open-label randomised controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS	2010	Lancet Oncol2010，11，：	1
12	Immunohistochemical identification of tissue factor in solid tumors显示文摘	Callander NS Varki N Rao LV	1992	Cancer1992，70，5：	1
13	Lenalidomiide plus highdose dex- amethasone versus lenalidomiide plus low - dose dexamethasone as initial therapy for newly diagnosed multiple myeloma:au openlabel randomized controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS Fonseca R Vesole DH Williams ME Abonour R Siegel DS Katz M Greipp PR Eastern Cooperative Oneology Group	2010	Lancet Oncol2010，11，1：	1
14	Lenalidomide plus highdose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma:an open-label randomised controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS		0，，：	1
15	Bortezomib- resistant nuclear factor-kappa B activity in multiple myeloma cells显示文摘	Markovina S Callander NS O'Connor SL	2008	Mol Cancer Res2008，6，8：	1
16	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS	2010	Lancet Oneol2010，11，1：	1
17	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial显示文摘	Rajkumar SV Jacobus S Callander NS	2010	Lancet Oneol2010，11，1：	1
18	Lenalidomide plus high - dose dexamethasone versus lenalidomide plus low -dose dexamethasone as initial therapy for newly diag- nosed muhiple myeloma : An open - label randomised con- trolled trial显示文摘	Rajkumar SV Jaeobus S Callander NS	2010	Lancet oncol2010，11，1：	1
19	Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma ceils Mol 显示文摘	Markovina S Callander NS Oconnor SL	2008	Cancer Res2008，6，8：	1
20	Bortezomib-resistant nuclear factor-kappaB activity in Multiple myeloma cells显示文摘	Markovina S Callander NS OConnor SL	2008	Mol Cancer Res2008，6，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示